VEGFA and macular holes: We measured the following parameters in the vitreous and serum obtained from PDR and macular hole (MH) patients: (i) the levels of PAO by evaluating Cu2+ reduction by all antioxidants present, (ii) the concentrations of HEL (a marker of early stage lipid peroxide), and (iii) the concentrations of VEGF.